Eucalyptus oil is a traditional herbal medicine widely used for a number of common ailments. Extreme toxicity following ingestion is well-documented, but public awareness is generally lacking. The toxic symptoms are rapid in onset, which include a burning sensation in the mouth and throat, abdominal pain, and spontaneous vomiting. The initial central nervous system (CNS) effects are giddiness, ataxia, and disorientation followed by loss of consciousness and convulsions occurring within 30 mins.
49 years female, known systemic hypertension, type 2 diabetes mellitus and hypothyroidism, presented to ER with alleged history of accidental ingestion of eucalyptus oil of approximately 10ml in her residence after which she had 3 episodes of watery vomiting followed by 2 epiodes of involuntary jerky movements involving all 4 limbs with uprolling of eyeballs, tongue bite and urinary incontinence.
Patient in ictal state.
Threatened – suctioning done, Oropharyngeal airway inserted.
RR – 28/ min, Spo2 – 66% RA – connected to high flow oxygen using NRBM. B/L air entry equal, B/L wheeze with harsh vesicular sounds heard .
BP – 170/ 100 mmHg. HR – 128/ min, CVS -Tachycardic, S1S2 normal, no murmur, JVP – Normal, PA – Soft, non-tender, no organomegally, bowel sounds heard.
Patient in status-Active GTCS+ , B/L PUPIL dilated. CBG – 260 mg/dl
Temp: 98.6o F Tongue bite with bloody frothy secretions noted.
pH – 6.780 PCO2 – 72.9 mmHg PO2 – 28 mmHg BE – -24 mmol/ L HCO3 – 10.8 mmol/ L LAC – >20 mmol/ L Na+ – 141 mmol/ L K+ – 3.3 mmol/ L Cl- – 104 mmol/ L BUN – 7 mg/dL CREAT – 1.1 mg/dL
pH – 7.34 PCO2 – 39 mmHg PO2 – 110 mmHg BE – -3 mmol/ L HCO3 – 21.5 mmol/ L LAC – 9.48 mmol/ L
Eucalyptus oil is commonly used in aromatherapy, topical ointments, and as a remedy for various respiratory conditions.
When eucalyptus oil is used, it can be absorbed through the skin, inhaled as vapor, or ingested in some cases.
The main active ingredient in eucalyptus oil responsible for potential seizures is often cineole (also known as eucalyptol).
Cineole can cross the blood-brain barrier and affect the central nervous system.
Cineole may disrupt the balance of neurotransmitters in the brain, particularly by affecting gamma-aminobutyric acid (GABA) and glutamate.
Cineole may reduce the inhibitory effects of GABA, an essential neurotransmitter that dampens neural activity and prevents excessive neuronal firing.
With reduced GABA inhibition, there can be an increase in glutamate activity, which is an excitatory neurotransmitter.
The imbalance between GABA and glutamate can lead to a state of excitotoxicity, where excessive neuronal firing and hyperactivity occur.
Excitotoxicity and neuronal hyperactivity can lower the seizure threshold in susceptible individuals.
In individuals with a lowered seizure threshold, the imbalance in neurotransmitters and hyperexcitability of neurons can trigger seizures.
Seizures may manifest in various forms, including tonic-clonic seizures, absence seizures, or focal seizures, depending on the specific brain regions affected.
The susceptibility to eucalyptus oil-induced seizures can vary among individuals. Factors such as dosage, individual sensitivities, and pre-existing neurological conditions play a role.
Every medical practitioner should possess knowledge about the potential toxic effects of eucalyptus oil, a substance commonly encountered in daily life in India. Given that there is no specific antidote available, it is imperative to provide supportive care in the emergency room. This care should include promptly addressing metabolic acidosis and ensuring the maintenance of hemodynamic parameters, which can lead to a swift recovery.
It’s worth noting that when eucalyptus oil is inhaled, CNS symptoms manifest more rapidly. This is due to the direct access of inhaled volatile oils to the brain, where they stimulate neurons. Consequently, it is essential to mandate warning labels on all products containing eucalyptus oil. Raising awareness about the health risks associated with eucalyptus oil among the public is crucial in order to prevent unnecessary complications.
For guiding me with the article, I would like to thank, Dr.Aslesha (Consultant & Clinical lead – Department Of Emergency Medicine) “The author declares no conflict of interest”
Dr. Silvera Samson Raj, Emergency Resident, Kauvery Hospital, Chennai.
Comment:*
Nickname*
E-mail*
Website
Save my name, email, and website in this browser for the next time I comment.